Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Phathom Pharmaceuticals Inc increased its cash reserves by 146.49%, or 228.37m. Cash Flow from Financing totalled 367.58m or 53,897.36% of revenues. In addition the company used 137.58m for operations while cash used for investing totalled 1.63m.
Cash flow per share | -5.13 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -3.99 |
---|---|
Tangible book value per share | -3.99 |
More ▼
Balance sheet in USDView more
Current ratio | 6.48 |
---|---|
Quick ratio | 6.44 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.86 |
More ▼